It's How Medicine Should Be®
<< Previous | New Search | Return to Search Results | Next >>

Physician Profile


call (888) 352-RUSH for help arranging an appointment

Gary L. Schaer, MD

Patient Feedback
  • Cardiology
  • Interventional Cardiology
  • Internal Medicine
Board Certification:
  • Cardiovascular Disease
  • Interventional Cardiology
  • Internal Medicine
Faculty Rank: Professor
Medical or Graduate Education: Yale University School of Medicine
Residency: New York Hospital-Cornell Medical Center - Internal Medicine
Fellowship: National Institutes of Health - Critical Care Medicine
  Georgetown University Hospital - Cardiology
Clinical Expertise:
  • Angina
  • Angiogram, coronary
  • Angioplasty
  • Coronary artery disease
  • Gene therapy, cardiovascular
  • Heart attack
  • Peripheral vascular disease (PVD)
  • Stem cell therapy, cardiovascular
  • Stent placement
Research Interests:
  • Clinical trials of new drugs and devices in interventional cardiovascular medicine
  • Gene therapy to stimulate angiogenesis
  • Cell therapies (stem cells, skeletal myoblasts) for heart failure following myocardial infarction
Languages Spoken:
  • Spanish
Google Map

Below is a list of scientific publications for which this practitioner was either the primary author or a contributor. Citations come from PubMed, a database of biomedical literature, life science journals and online books. PubMed is a service of the US Library of Medicine at the National Institutes of Health. Click on the title of the cited work for more information (this will take you directly to Listings go back five years.

  1. Impact of a Novel Interventional Platform and Hospital Design on the Door-to-balloon Time in Patients Presenting With ST-segment Elevation Myocardial Infarction.
    Poulin MF, Appis A, Purim-Shem-Tov Y, Schaer GL, Snell J
    Crit Pathw Cardiol
    2015 Mar
  2. Implementation of miRNAs to Reduce In-Stent Restenosis in the Future.
    Schaer GL, Zhang C
    J. Am. Coll. Cardiol.
    2015 Jun 2
  3. An Endocrine Genetic Signal Between Blood Cells and Vascular Smooth Muscle Cells: Role of MicroRNA-223 in Smooth Muscle Function and Atherogenesis.
    Shan Z, Qin S, Li W, Wu W, Yang J, Chu M, Li X, Huo Y, Schaer GL, Wang S, Zhang C
    J. Am. Coll. Cardiol.
    2015 Jun 16
  4. Adverse Outcomes in Hospitalized Patients Who Develop ST-elevation Myocardial Infarction.
    Richmond T, Holoshitz N, Haryani A, Purim-Shem-Tov Y, Sharma G, Schaer GL
    Crit Pathw Cardiol
    2014 Jun
  5. Successful collaborative model for STEMI care between a STEMI-referral and a STEMI receiving center.
    Purim-Shem-Tov YA, Schaer GL, Malik K, McLaughlin RR, Haw JM, Melgoza NA, Franco MM
    Crit Pathw Cardiol
    2014 Dec
  6. An open-label dose escalation study to evaluate the safety of administration of nonviral stromal cell-derived factor-1 plasmid to treat symptomatic ischemic heart failure.
    Penn MS, Mendelsohn FO, Schaer GL, Sherman W, Farr M, Pastore J, Rouy D, Clemens R, Aras R, Losordo DW.
    Circ Res. 2013
    2013 Mar 1
    112(5):816-25. doi: 10.1161/CIRCRESAHA.111.300440. Epub 2013 Feb 21.
  7. A phase 3, randomized, double-blinded, active-controlled, unblinded standard of care study assessing the efficacy and safety of intramyocardial autologous CD34+ cell administration in patients with refractory angina: design of the RENEW study.
    Povsic TJ, Junge C, Nada A, Schatz RA, Harrington RA, Davidson CJ, Fortuin FD, Kereiakes DJ, Mendelsohn FO, Sherman W, Schaer GL, White CJ, Stewart D, Story K, Losordo DW, Henry TD
    Am. Heart J.
    2013 Jun
  8. Assessment of safety, accuracy, and human CD34+ cell retention after intramyocardial injections with a helical needle catheter in a porcine model.
    Kumar A, Haralampus CA, Hughes M, Rouy D, Cresswell N, Braun R, Turner D, Amrani D, Motlagh D, Schaer GL.
    Catheter Cardiovasc Interv. 2012
    2012 May 14. doi: 10.1002/ccd.24476. [Epub ahead of print]
  9. Achieving high quality in ST-segment elevation myocardial infarction care: one urban academic medical center experience.
    Purim-Shem-Tov YA, Melgoza N, Haw J, Schaer GL, Calvin JE, Rumoro DP.
    Crit Pathw Cardiol. 2012
    2012 Mar
    11(1):32-9. doi: 10.1097/HPC.0b013e31824303f1.
  10. Therapeutic angiogenesis for the management of refractory angina: current concepts.
    Attanasio S, Schaer G.
    Cardiovasc Ther. 2011
    2011 Dec
    29(6):e1-e11. doi: 10.1111/j.1755-5922.2010.00153.x. Epub 2010 Apr 9. Review.
  11. Outcomes of unselected recipients of sirolimus-eluting stents: the Cypher stent U.S. post-marketing surveillance registry.
    Bezerra H, Perin E, Berger P, Block P, Ramee S, Katz S, Kellet M, Dippel E, Schaer G, Britto S, Cohen S, Costa M.
    J Invasive Cardiol. 2010
    2010 Feb
  12. A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction.
    Hare JM, Traverse JH, Henry TD, Dib N, Strumpf RK, Schulman SP, Gerstenblith G, DeMaria AN, Denktas AE, Gammon RS, Hermiller JB Jr, Reisman MA, Schaer GL, Sherman W.
    J Am Coll Cardiol. 2009
    2009 Dec 8
    54(24):2277-86. doi: 10.1016/j.jacc.2009.06.055.
  • View Transcript

More Videos

Stem Cell Research for Heart and Vascular Diseases

Patient feedback information is available for physicians employed by Rush University Medical Center who have received 30 or more patient surveys. Responses are measured on a scale of 1 to 5, with 5 being the best score.
Number of Patient Surveys
Friendliness/courtesy of the care provider
Explanations the care provider gave you about your problem or condition
Concern the care provider showed for your questions or worries
Likelihood of your recommending this care provider to others
Care provider's efforts to include you in decisions about your treatment
Information the care provider gave you about medications
Instructions the care provider gave you about follow-up care
Your confidence in this care provider
Degree to which care provider talked with you using words you could understand
Amount of time the care provider spent with you
For more information about patient feedback, see the Quality Care section of the Rush University Medical Center website.